• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 3
  3. Author

Online ISSN: 2515-8260

Volume9, Issue3

PREDICTORS OF MORTALITY IN PATIENTS WITH CONCOMITANT AND SEQUENTIAL COVID -19 ASSOCIATED MUCORMYCOSIS - A CROSS SECTIONAL STUDY IN A TERTIARY CARE CENTER

    MUMTAZ ALI KHAN, PRABHU S, SACHIN K S , AISHWARYA NAIR, HEMANTH SRIVATSAVA REDDY SANJAMALA .

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 3, Pages 2605-2612

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Introduction: Mortality rates for COVID-19-related mucormycosis vary greatly in reported studies. A systematic evaluation of 101 cases revealed a fatality rate of 30.7 percent. However, research on the determinants of death in COVID-19 associated mucormycosis is insufficient. The purpose of this study was to find out what factors contributed to in-hospital mortality in patients with COVID-19-related mucormycosis.
Objectives:
To study the the Clinical profile , Haematological ,Biochemical and Radiological  changes associated with mortality in patients with covid-19  associated mucormycosis.
Methodology: In this single-center, observational study, 130 patients diagnosed with COVID-19 associated mucormycosis were recruited from a tertiary level intensive care unit from Bowring and Lady Curzon hospital, Bangalore, India.
Results: Proportion of HTN, IHD, CKD and HIV was significantly more in non survivors compared to survivors. ICU admission and Oxygen requirement was scientifically higher in Non Survivors and had significant association with the outcome. .  There was no significant difference in the levels of Hb, Neutrophils, Lymphocytes, Monocytes, Eosinophils, and Platelets as p>0.05. Total count (17191±7764), ESR (57.6±12.4), CRP levels (199.0±69.5), and S.Ferritin (624.6±268.0) were significantly higher among the Non survivors. S.LDH (355.7±108.9), S.Free Iron (51.7±13.3), HBA1C (11.4±2.4), and S.Urea (36.9±35.3) were also found to be significantly higher among the non survivors.
Conclusion: The current study highlights that a multidisciplinary approach in COVID-19 associated mucormycosis patients that includes timely and effective surgical debridement coupled with appropriate antifungal therapy and diligent sugar monitoring with intrahospital glycemic control may help to lower mortality.
Keywords:
    Mortality rates for COVID-19-related mucormycosis vary greatly in reported studies
  • PDF (133 K)
  • XML
(2022). PREDICTORS OF MORTALITY IN PATIENTS WITH CONCOMITANT AND SEQUENTIAL COVID -19 ASSOCIATED MUCORMYCOSIS - A CROSS SECTIONAL STUDY IN A TERTIARY CARE CENTER. European Journal of Molecular & Clinical Medicine, 9(3), 2605-2612.
MUMTAZ ALI KHAN, PRABHU S, SACHIN K S , AISHWARYA NAIR, HEMANTH SRIVATSAVA REDDY SANJAMALA .. "PREDICTORS OF MORTALITY IN PATIENTS WITH CONCOMITANT AND SEQUENTIAL COVID -19 ASSOCIATED MUCORMYCOSIS - A CROSS SECTIONAL STUDY IN A TERTIARY CARE CENTER". European Journal of Molecular & Clinical Medicine, 9, 3, 2022, 2605-2612.
(2022). 'PREDICTORS OF MORTALITY IN PATIENTS WITH CONCOMITANT AND SEQUENTIAL COVID -19 ASSOCIATED MUCORMYCOSIS - A CROSS SECTIONAL STUDY IN A TERTIARY CARE CENTER', European Journal of Molecular & Clinical Medicine, 9(3), pp. 2605-2612.
PREDICTORS OF MORTALITY IN PATIENTS WITH CONCOMITANT AND SEQUENTIAL COVID -19 ASSOCIATED MUCORMYCOSIS - A CROSS SECTIONAL STUDY IN A TERTIARY CARE CENTER. European Journal of Molecular & Clinical Medicine, 2022; 9(3): 2605-2612.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 48
  • PDF Download: 83
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus